ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Skin Diseases
Immune System Diseases
Eczematous Skin Diseases
Food Hypersensitivity
Genetic Skin Diseases

Eczema trials near Indianapolis, IN, USA:

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...

Enrolling
Eczema
Drug: Abrocitinib
Other: Placebo

Phase 3

Pfizer
Pfizer

Indianapolis, Indiana, United States of America and 46 other locations

Locations recently updated

in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema is a condition which can cause dryness, itchin...

Enrolling
Atopic Dermatitis
Drug: Tilrekimig
Drug: Dupilumab

Phase 3

Pfizer
Pfizer

Indianapolis, Indiana, United States of America and 31 other locations

This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in childr...

Enrolling
Atopic Dermatitis
Drug: Abrocitinib

Phase 3

Pfizer
Pfizer

Indianapolis, Indiana, United States of America and 38 other locations

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Enrolling
Eczema Atopic Dermatitis
Eczema, Atopic
Drug: Camoteskimab
Drug: Placebo

Phase 2

Apollo Therapeutics

Indianapolis, Indiana, United States of America and 84 other locations

Locations recently updated

This is a first-in-human, Phase 1, double-blind, randomized, placebo-controlled, dose-escalation study evaluating ARQ-234. The study is designed to a...

Enrolling
Eczema
Atopic Dermatitis (AD)
Drug: Placebo
Biological: ARQ-234

Phase 1

Arcutis Biotherapeutics
Arcutis Biotherapeutics

Plainfield, Indiana, United States and 6 other locations

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Active, not recruiting
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

Phase 2

Bluefin Biomedicine, Inc.

Plainfield, Indiana, United States of America and 88 other locations

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...

Active, not recruiting
Atopic Dermatitis
Drug: Dupilumab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Plainfield, Indiana, United States and 83 other locations

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Indianapolis, Indiana, United States and 60 other locations

Status recently updated

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Active, not recruiting
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

Phase 2

Pfizer
Pfizer

Indianapolis, Indiana, United States of America and 100 other locations

This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...

Active, not recruiting
Moderate to Severe Atopic Dermatitis
Drug: Rezpegaldesleukin
Drug: Placebo

Phase 2

Nektar Therapeutics
Nektar Therapeutics

Indianapolis, Indiana, United States and 118 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems